Phimedix PLC Notice of AGM and AIM Rule 15 Update (7997Y)
September 11 2020 - 10:33AM
UK Regulatory
TIDMPHM
RNS Number : 7997Y
Phimedix PLC
11 September 2020
11 September 2020
Phimedix Plc
("Phimedix" or "the Company")
Notice of Annual General Meeting and AIM Rule 15 Update
Phimedix (AIM: PHM) confirms that the Annual Report &
Accounts for the year ended 31 March 2020, together with the Notice
of its Annual General Meeting ("AGM") and Form of Proxy, have been
posted to shareholders and are available on the Company's website
www.phimedix.com . The AGM is to be held at 10.00 a.m. on 5 October
2020, at Bracher Rawlins LLP, 77 Kingsway, London WC2B 6SR.
In accordance with Government legislation and related
restrictions in response to COVID-19, and to minimise public health
risks, the General Meeting is to be held as a closed meeting unless
both the coronavirus (COVID-19) situation and the applicable
guidance have changed prior to the date of the meeting. Unless
Shareholders are notified otherwise by the Company prior to the
date of the General Meeting, the arrangements for the meeting shall
be that neither Shareholders, nor their proxies nor corporate
representatives will be permitted to attend the meeting in person.
As such, Shareholders are strongly encouraged to appoint the
Chairman of the General Meeting to act as their proxy as no other
person will be permitted to attend the meeting.
AIM Rule 15 update
The London Stock Exchange is expected to suspend trading in the
Company's ordinary shares on AIM, pursuant to Rule 15 of the AIM
Rules, at 7.30 am on 14 September 2020. In the event that no
reverse takeover is completed in the six months after that date,
the London Stock Exchange will cancel the admission of the
Company's ordinary shares to trading on AIM.
Phimedix Plc Please email any enquiries
Nicholas Nelson, Director to nelson@nexfin.org.uk
Ajay Rajpal, Director
SPARK Advisory Partners Limited (Nominated
Adviser)
Mark Brady or Neil Baldwin
www.sparkadvisorypartners.com +44 (0) 203 368 3550
SI Capital Ltd (Broker)
Nick Emerson
www.sicapital.co.uk +44 (0)1483 413500
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOAGPUUWBUPUGCG
(END) Dow Jones Newswires
September 11, 2020 10:33 ET (14:33 GMT)
Phimedix (LSE:PHM)
Historical Stock Chart
From Nov 2024 to Dec 2024
Phimedix (LSE:PHM)
Historical Stock Chart
From Dec 2023 to Dec 2024